A detailed history of Gamma Investing LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 76 shares of SAGE stock, worth $416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76
Previous 134 43.28%
Holding current value
$416
Previous $1.46 Million 62.27%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$7.02 - $13.08 $407 - $758
-58 Reduced 43.28%
76 $549,000
Q2 2024

Jul 02, 2024

BUY
$10.58 - $17.9 $190 - $322
18 Added 15.52%
134 $1.46 Million
Q1 2024

Apr 05, 2024

BUY
$18.62 - $26.95 $968 - $1,401
52 Added 81.25%
116 $2.17 Million
Q4 2023

Feb 01, 2024

BUY
$17.1 - $22.26 $1,094 - $1,424
64 New
64 $1.64 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.